(Q43098008)

13 November 2017

Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography (English)

1 reference

contrast-induced nephropathy

13 November 2017

1 reference

1 reference

1 reference

Hakan Ozhan

1

1 reference

13 November 2017

Ismail Erden

2

1 reference

13 November 2017

Serkan Ordu

3

1 reference

13 November 2017

Mesut Aydin

4

1 reference

13 November 2017

Onur Caglar

5

1 reference

13 November 2017

Cengiz Basar

6

1 reference

13 November 2017

Subhan Yalcin

7

1 reference

13 November 2017

Recai Alemdar

8

1 reference

13 November 2017

14 April 2010

1 reference

13 November 2017

1 reference

13 November 2017

61

1 reference

13 November 2017

711-714

1 reference

13 November 2017

7

1 reference

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

13 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Postischemic acute renal failure is reduced by short-term statin treatment in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Contrast-induced nephropathy: a clinical and evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Statin effects beyond lipid lowering--are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

Effects of atorvastatin on arterial endothelial function in coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710364216

21 January 2018

Identifiers

DOI

10.1177/0003319710364216

1 reference

13 November 2017

1 reference